Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis

NCT04282941 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Persistent Ductus Arteriosus

Interventions

DRUG: Ibuprofen in continuous (24 hours) iv infusion and EchoG
DRUG: IV bolus Ibuprofen slow (15 minutes) and EchoG

Sponsor

Instituto de Investigación Hospital Universitario La Paz